The global immunoassay market is expected to grow during forecast period owing to driving factors such as increase in geriatric population, increase in prevalence of chronic diseases, rise in incidence of infectious diseases such as hepatitis, dengue, AIDS and others. Furthermore, advancement in technologies, expansion in biotechnology & pharmaceutical companies and launch of novel immunoassay products are expected to offer new opportunities in growth of market.
Immunoassay is a test that measures concentration of small molecules such as protein, lipids, nucleic acids etc. in solutions using antigen antibody reactions. Immunoassay is a quick and accurate test used to identify specific molecules in medical and research field. At industry level, the immunoassays are used to detect the contaminants in food and water as well as quality control to monitor specific molecule used in the process.
The "Global Immunoassay Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global medical device market trend analysis. The report aims to provide an overview of immunoassay market with detailed market segmentation by product, technology, application, end user and geography. The global immunoassay market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Immunoassay market players and offers key trends and opportunities in the market.
1. Siemens Healthcare Private Limited
3. bioMerieux SA
5. F. Hoffmann-La Roche Ltd
7. Ortho Clinical Diagnostics
8. Sysmex Corporation
9. Thermo Fisher Scientific Inc.
10. Quidel Corporation
The report analyzes factors affecting immunoassay market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the immunoassay market in these regions.
The global immunoassay market is segmented on the basis of product, technology, application and end user. Based on product, the market is segmented as reagents & kits, analyzers/instruments, software & services. On the basis of technology, the global immunoassay market is segmented into enzyme-linked immunosorbent assays (ELISA), fluorescence, chemiluminescence, rapid test, western blot, enzyme-linked immune absorbent spot (ELISPOT) and PCR. Based on application, the market is segmented as therapeutic drug monitoring, oncology, cardiology, endocrinology, infectious disease testing, autoimmune diseases and others. Based on end user, the market is segmented as hospitals, blood banks, clinical laboratories, pharmaceutical and biotech companies, academic research centers, others.
Inquire for Discount: https://www.theinsightpartners.com/discount/TIPRE00005380/
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global immunoassay market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The immunoassay market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Media, Healthcare and Telecommunication industries.